NCT03974932 - Total Knee Arthroplasty (TKA) Study of HTX-011 in an Multimodal Analgesic Regimen (MMA) Regimen | Biotech Hunter

Enrollment

116

Participants

Timeline

Start Date

June 5, 2019

Primary Completion Date

December 7, 2020

Study Completion Date

January 7, 2021

Conditions

Analgesia

Interventions

DRUG

HTX-011

Dual-acting local anesthetic. Dose 1.

DRUG

Ibuprofen

NSAID.

DRUG

Acetaminophen

Analgesic.

DRUG

Celecoxib

NSAID.

DRUG

+/- Bupivacaine HCl

Local anesthetic.

DEVICE

Luer Lock Applicator

Applicator for instillation.

DRUG

HTX-011

Dual-acting local anesthetic. Dose 2.

Trial Locations (6)

Phoenix Clinical Research, LLC, Tamarac

Helen Keller Hospital, Sheffield

Midwest Clinical Research Center, LLC, Dayton

Plano Surgical Hospital, Plano

First Surgical Hospital, Bellaire

Endeavor Clinical Trials, LLC., San Antonio